GDM: Postpartum management to reduce long-term risks

Current Diabetes Reports

Volumn 8, Issue 4, 2008, Pages 287-293

  Khandelwal, Meena ^a  

^a Department of Anesthesiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; COPPER INTRAUTERINE DEVICE; ETHINYLESTRADIOL; GESTAGEN; GLITAZONE DERIVATIVE; GLUCOSE; LEVONORGESTREL; METFORMIN; PIOGLITAZONE; PLACEBO; PROGESTERONE; ROSIGLITAZONE; TETRAHYDROLIPSTATIN; TROGLITAZONE;

BEHAVIOR MODIFICATION; BREAST FEEDING; CARDIOVASCULAR DISEASE; CHILD CARE; CLINICAL TRIAL; CONTRACEPTION; DIABETES EDUCATION; DIARRHEA; DIET THERAPY; DRUG EFFICACY; DRUG WITHDRAWAL; FLATULENCE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIFESTYLE MODIFICATION; LOW CARBOHYDRATE DIET; LOW FAT DIET; METABOLIC SYNDROME X; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATIENT COUNSELING; PHYSICAL ACTIVITY; PREGNANCY DIABETES MELLITUS; PUERPERIUM; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SIDE EFFECT; STOMACH BYPASS; WEIGHT GAIN; WEIGHT REDUCTION; DIABETES MELLITUS; FEMALE; PATHOPHYSIOLOGY; PREGNANCY;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HUMANS; POSTPARTUM PERIOD; PREGNANCY;

EID: 52649126316     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-008-0051-9     Document Type: Review

References (40)

1. Mokdad AH, Ford ES, Bowman BA, et al.: Diabetes trends in the U.S.: 1990-1998. Diabetes Care 2000, 23:1278-1283.
2. National Center for Chronic Disease Prevention and Health Promotion; Centers for Disease Control: National Diabetes Fact Sheet. Available at http://www.cdc.gov/diabetes/pubs/factsheet.htm. Accessed March 2008.
3. Hogan P, Dall T, Nikolov P, et al.: Economic costs of diabetes in the US in 2002. Diabetes Care 2003, 26:917-932.
4. American Diabetes Association: Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008, 31:596-615.
5. Vambergue A, Dognin C, Boulogne A, et al.: Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study. Diabet Med 2008, 25:58-64.
6. Lee AJ, Hiscock RJ, Wein P, et al.: Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 2007, 30:878-883.
7. Schranz AG, Savona-Ventura C: Long-term significance of gestational carbohydrate intolerance: a longitudinal study. Exp Clin Endocrinol Diabetes 2002, 110:219-222.
8. Oldfield MD, Donley P, Walwyn L, et al.: Long term prognosis of women with gestational diabetes in a multiethnic population. Postgrad Med J 2007, 83:426-430.
9. Linne Y, Barkeling B, Rossner S, et al.: Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. BJOG 2002, 109:1227-1231.
10. Dabelea D: The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care 2007, 30(Suppl 2):S169-S174.
11. Clausen TD, Mathiesen ER, Hansen T, et al.: High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008, 31:340-346.
12. Gregory KD, Kjos SL, Peters RK: Cost of non-insulin-dependent diabetes in women with a history of gestational diabetes: implications for prevention. Obstet Gynecol 1993, 81(Pt 1)):782-786.
13. Dinh D-TP, Musser J, Bayliss PM: Does postpartum diabetic testing occur in gestational diabetics? Primary Care Update for OB/ GYNS 2003, 10:182-185.
14. Smirnakis KV, Chasan-Taber L, Wolf M, et al.: Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol 2005, 106:1297-1303.
15. Kim C, McEwen LN, Kerr EA, et al.: Preventive counseling among women with histories of gestational diabetes mellitus. Diabetes Care 2007, 30:2489-2495.
16. Kitzmiller JL, Dang-Kilduff L, Taslimi MM: Gestational diabetes after delivery: short-term management and long-term risks. Diabetes Care 2007, 30(Suppl 2):S225-S235.
17. Holt RI, Goddard JR, Clarke P, et al.: A postnatal fasting plasma glucose is useful in determining which women with gestational diabetes should undergo a postnatal oral glucose tolerance test. Diabet Med 2003, 20:594-598.
18. American Diabetes Association: Standards of medical care in diabetes - 2008. Diabetes Care 2008, 31(Suppl 1):S12-S54.
19. Metzger BE, Buchanan TA, Coustan DR, et al.: Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007, 30(Suppl 2):S251-S260.
20. Taylor JS, Kacmar JE, Nothnagle M, et al.: A systematic review of the literature associating breastfeeding with type 2 diabetes and gestational diabetes. J Am Coll Nutr 2005, 24:320-326.
21. Mayer-Davis EJ, Dabelea D, Lamichhane AP, et al.: Breast-feeding and type 2 diabetes in the youth of three ethnic groups: the SEARCH for Diabetes in Youth Case-Control Study. Diabetes Care 2008, 31:470-475.
22. Peters RK, Kjos SL, Xiang A, Buchanan TA: Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996, 347:227-230.
23. Kjos SL, Peters RK, Xiang A, et al.: Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 1998, 280:533-538.
24. Damm P, Mathiesen ER, Petersen KR, Kjos S: Contraception after gestational diabetes. Diabetes Care 2007, 30(Suppl 2):S236-S241.
25. Xiang AH, Kawakubo M, Kjos SL, et al.: Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care 2006, 29:613-617.
26. Truitt ST, Fraser AB, Grimes DA, et al.: Combined hormonal versus nonhormonal versus progestin-only contraception in lactation. Cochrane Database Syst Rev 2003 (2):CD003988.
27. Swan W, Kilmartin G, Liaw ST, et al.: Assessment of readiness to prevent type 2 diabetes in a population of rural women with a history of gestational diabetes. Rural Remote Health 2007, 7:802.
28. American Diabetes Association: Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008, 31(Suppl 1):S61-S78.
29. Gillen LJ, Tapsell LC, Gillen LJ, Tapsell LC: Advice that includes food sources of unsaturated fat supports future risk management of gestational diabetes mellitus. J Am Diet Assoc 2004, 104:1863-1867.
30. Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
31. Zhang C, Solomon CG, Manson JE, et al.: A prospective study of pregravid physical activity and sedentary behaviors in relation to the risk for gestational diabetes mellitus. Arch Intern Med 2006, 166:543-548.
32. Mottola MF, Mottola MF: The role of exercise in the prevention and treatment of gestational diabetes mellitus. Curr Sports Med Rep 2007, 6:381-386.
33. Norris SL, Zhang X, Avenell A, et al.: Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 2004, 164:1395-1404.
34. Buchanan TA, Xiang AH, Peters RK, et al.: Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002, 51:2796-2803.
35. Xiang AH, Peters RK, Kjos SL, et al.: Effect of pioglitazone on pancreatic beta-ccll function and diabetes risk in Hispanic women with prior gestational diabetes. Diabetes 2006, 55:517-522.
36. Chiasson JL, Josse RG, Gomis R, et al.: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002, 359:2072-2077.
37. Chiasson JL, Josse RG, Gomis R, et al.: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003, 290:486-494.
38. Torgerson JS, Hauptman J, Boldrin MN, et al.: XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004, 27:155-161. (Published erratum appears in Diabetes Care 2004, 27:856.)
39. Bo S, Monge L, Macchetta C, et al.: Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome. J Endocrinol Invest 2004, 27:629-635.
40. HAPO Study Cooperative Research Group: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Gynaecol Obstet 2002, 78:69-77.